The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Multicentric Castleman Disease: Diagnosis and Management

Rare lymphoproliferative disorder with cytokine storm and targeted therapy options

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Multicentric Castleman Disease: Diagnosis and Management?

MCD encompasses heterogeneous group of disorders distinguished by HHV-8 status into HHV-8-associated MCD (often HIV-associated) and idiopathic MCD (iMCD).

Histopathologic classification includes hyaline vascular variant, plasma cell variant and mixed variant with prognostic implications.

iMCD subtypes include thrombocytopenia, anasarca, fever, reticulin myelofibrosis, organomegaly (TAFRO) and not-otherwise-specified (NOS) types.

Cytokine dysregulation particularly IL-6 hypersecretion drives systemic inflammation, B-cell proliferation and clinical manifestations.

Diagnosis requires excisional lymph node biopsy with characteristic histopathology, exclusion of mimics and clinical/laboratory criteria.

Symptoms

Generalized lymphadenopathy involving multiple lymph node stations.
Systemic inflammatory symptoms with fever, night sweats, weight loss and fatigue.
Hepatosplenomegaly with abdominal discomfort and possible portal hypertension.
Cytopenias from bone marrow involvement or autoimmune phenomena.
TAFRO syndrome features with thrombocytopenia, anasarca with edema and ascites, organomegaly and reticulin fibrosis.

Risk Factors

HIV infection particularly with low CD4 counts as major risk factor for HHV-8-associated MCD.
HHV-8 infection (Kaposi sarcoma-associated herpesvirus) drives subset of cases.
No clearly established environmental risk factors for idiopathic MCD.
Genetic predisposition with rare familial cases reported.
Autoimmune background and inflammatory conditions in some patients.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Generalized lymphadenopathy with systemic symptoms requires prompt hematology and infectious disease evaluation.
  • Suspected MCD warrants comprehensive workup including HIV and HHV-8 testing alongside excisional biopsy.
  • TAFRO presentation with thrombocytopenia, anasarca and organomegaly needs urgent multidisciplinary evaluation.
  • Cytokine storm features with severe inflammation and organ dysfunction require intensive care consideration.
  • Long-term follow-up with regular monitoring is essential given relapsing disease course.

Treatment Methods

01
Anti-IL-6 therapy with siltuximab is first-line for idiopathic MCD with significant clinical responses.
02
Antiviral therapy and chemotherapy for HHV-8-associated MCD with rituximab-based regimens often effective.
03
Combination therapy with rituximab and chemotherapy for severe or refractory disease.
04
Tocilizumab as IL-6 receptor antagonist alternative for selected patients.
05
Comprehensive care including subtype-directed treatment, supportive care for cytokine storm, monitoring for treatment response with biomarkers (CRP, IL-6), management of complications, infection prophylaxis and clinical trial enrollment for refractory cases optimize outcomes in this complex disease.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.